Turn Therapeutics Inc.
TTRX
$13.75
$1.098.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -371.61% | -195.59% | 186.38% | -185.74% | -218.54% |
| Total Depreciation and Amortization | 16.00% | 16.94% | 14.52% | 13.22% | 8.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,641.68% | -81.32% | -4,659.21% | -84.15% | 50.77% |
| Change in Net Operating Assets | -41.88% | -139.43% | 535.81% | 4,194.22% | 893.13% |
| Cash from Operations | -84.68% | -447.74% | -173.24% | -56.42% | -80.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 81.76% | -- | -302.56% | -106.44% | -31.95% |
| Cash from Investing | 81.76% | 23.27% | -302.56% | -106.44% | -31.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 7.20% | 508.52% | 83.80% | 1,300.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 680.14% | 508.52% | 83.80% | 1,300.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.45% | 777.36% | 2,250.84% | 12.89% | 1,192.77% |